Physician

John D Kolstoe, MD

According to 2025 Medicare claims, John Kolstoe, MD (NPI: 1124043229) practices internal medicine in the Lansing-East Lansing, MI market, with the plurality of this provider's patient population coming from Ingham, MI. This provider's primary affiliated billing organization is JOSHUA P JUNE DO (NPI: 1942836663; TIN: 833133224) and primary practice location at 48917-4100. Kolstoe is affiliated with the POM ACO (ACO ID: A1297), participating under the MSSP model.

Kolstoe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 260 traditional Medicare patients, billed 15,173 HCPCS/CPT codes, and received $243,228 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 3,034 prescription claims across 295 beneficiaries totaling $429,375 in drug costs, led by Enbrel Sureclick (Etanercept). 2016 DME data shows 24 claims. Open Payments data shows 125 records totaling $1,872. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $100,769 and ending at $243,228. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $714,918 and ending at $429,375. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	331	1,337	$100,769
2016	295	757	$50,876
2017	151	319	$21,797
2018	233	525	$31,031
2019	312	781	$43,172
2020	284	689	$41,021
2021	194	371	$26,233
2022	109	1,374	$40,405
2023	258	9,983	$169,301
2024	260	15,173	$243,228

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	374	6,386	$714,918
2016	350	4,334	$614,963
2017	334	2,367	$337,038
2018	435	4,672	$1,160,975
2019	413	4,835	$1,522,722
2020	390	5,036	$1,216,793
2021	348	3,544	$746,695
2022	265	1,775	$283,942
2023	243	2,777	$279,502
2024	295	3,034	$429,375

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	22	$1,988
2016	N/R	24	$1,118
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	49	75	$113
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	155	227	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	89	112	$62
J0897	Injection, denosumab, 1 mg	56	3,600	$20
96372	Injection of drug or substance under skin or into muscle	68	106	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	11	308	$81,619
Ipratropium Bromide	Ipratropium Bromide	347	7,632	$10,132
Diflunisal	Diflunisal	78	3,035	$7,152
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	67	4,901	$5,176
Fluticasone Propionate	Fluticasone Propionate	353	15,229	$4,917

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	125	$1,872	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John D. Kolstoe, MD?

Tedicare shows public-source Medicare data for John D. Kolstoe, MD (NPI 1124043229), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John D. Kolstoe, MD have ACO affiliation data?

John D. Kolstoe, MD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297).

What billing organization is linked to John D. Kolstoe, MD?

John D. Kolstoe, MD is linked to JOSHUA P JUNE DO (billing NPI 1942836663) in the available physician profile data.

Does John D. Kolstoe, MD have Open Payments data?

John D. Kolstoe, MD has 125 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.